FDP
ADMA icon

Financiere des Professionnels’s ADMA Biologics ADMA Stock Holding History

Financiere des Professionnels’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-70,832
Closed -$638K – 346
2026
Q1 		$638K Buy
+70,832
New +$1.12M 0.04% 225

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Financiere des Professionnels's ADMA Position: Q2 2026 in Review

Financiere des Professionnels sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 70,832 shares — an estimated $638K sold.

Financiere des Professionnels first reported a position in ADMA in Q1 2026 and held it in 1 quarter. The position peaked at $638K in Q1 2026. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Financiere des Professionnels reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Financiere des Professionnels sold 70,832 ADMA Biologics shares in Q2 2026, an estimated $638K.
  • Financiere des Professionnels first reported a position in ADMA Biologics in Q1 2026 and held it in 1 quarter.
  • Financiere des Professionnels's ADMA Biologics position peaked at $638K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.